Literature DB >> 3790073

Wavelength-dependence of the relative rate constants for the main geometric and structural photoisomerization of bilirubin IX alpha bound to human serum albumin. Demonstration of green light at 510 nm as the most effective wavelength in photochemical changes from (ZZ)-bilirubin IX alpha to (EZ)-cyclobilirubin IX alpha via (EZ)-bilirubin.

S Onishi, S Itoh, K Isobe.   

Abstract

The kinetics for the quantitatively important reaction: (Formula: see text) that is, the photochemical interconversion between bilirubin and its geometric and structural photoisomers bound to human serum albumin in aqueous solution when various wavelengths of monochromatic light were used, were assayed by h.p.l.c. In order to clarify the wavelength-dependence of the relative rate constants in the individual steps, a light-source with a half-bandwidth of 10 nm was used at increments of 20 nm, in the range from 410 nm to 550 nm. We describe for the first time studies on the wavelength-dependence of rate constants in geometric and structural photoisomerization reactions in vitro of (ZZ)-bilirubin or (EZ)-bilirubin bound to human serum albumin, especially the relative rate constants of cyclization of (EZ)-bilirubin into (EZ)-cyclobilirubin. Because studies in vitro have demonstrated that the wavelengths from 350 to 450 nm are mutagenic, the results obtained indicated that the safest and ideal light-source for phototherapy is green light of 510 nm, which keeps (ZE)-bilirubin concentrations as low as possible, as shown by a maximal value of k2 at 510 nm and a relatively low value of k1 at 510 nm. This light-source still ensures the substantial absorption of (ZZ)-bilirubin, which is the precursor of (EZ)-bilirubin, the intermediate in (EZ)-cyclobilirubin formation and, furthermore, as shown by the maximal value of k5 and a considerable value of k4 at 510 nm, promotes the cyclization of (EZ)-bilirubin derived from (ZZ)-bilirubin even though k3 at 510 nm also shows a peak value.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3790073      PMCID: PMC1146781          DOI: 10.1042/bj2360023

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  New light in phototherapy.

Authors:  C Vecchi; G P Donzelli; M G Migliorini; G Sbrana; R Pratesi
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

2.  High-pressure liquid chromatographic analysis of anaerobic photoproducts of bilirubin-IX alpha in vitro and its comparison with photoproducts in vivo.

Authors:  S Onishi; N Kawade; S Itoh; K Isobe; S Sugiyama
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

3.  Demonstration of a geometric isomer of bilirubin-IX alpha in the serum of a hyperbilirubinaemic newborn infant and the mechanism of jaundice phototherapy.

Authors:  S Onishi; K Isobe; S Itoh; N Kawade; S Sugiyama
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

4.  Concerning the structure of photobilirubin II.

Authors:  M S Stoll; N Vicker; C H Gray; R Bonnett
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

5.  Quantum yield and equilibrium position of the configurational photoisomerization of bilirubin bound to human serum albumin.

Authors:  A A Lamola; J Flores; F H Doleiden
Journal:  Photochem Photobiol       Date:  1982-05       Impact factor: 3.421

6.  Photoisomerized bilirubin in blood from infants receiving phototherapy.

Authors:  A A Lamola; W E Blumberg; R McClead; A Fanaroff
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

7.  Kinetics of the photochemical interconversion among geometric photoisomers of bilirubin.

Authors:  K Isobe; S Onishi
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

8.  Phototherapy: a new twist to bilirubin.

Authors:  A F McDonagh
Journal:  J Pediatr       Date:  1981-12       Impact factor: 4.406

9.  A spectrum response study on single strand DNA breaks, sister chromatid exchanges, and lethality induced by phototherapy lights.

Authors:  E G Sideris; G C Papageorgiou; S C Charalampous; E M Vitsa
Journal:  Pediatr Res       Date:  1981-07       Impact factor: 3.756

10.  Light-induced chromatid damage in human skin fibroblasts in culture in relation to their neoplastic potential.

Authors:  R Parshad; R Gantt; K K Sanford; G M Jones; R F Camalier
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

View more
  4 in total

1.  The effect of bilirubin photoisomers on unbound-bilirubin concentrations estimated by the peroxidase method.

Authors:  S Itoh; T Yamakawa; S Onishi; K Isobe; M Manabe; K Sasaki
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

2.  Action spectrum of phototherapy in hyperbilirubinemic neonates.

Authors:  Finn Ebbesen; Mette L Donneborg; Pernille K Vandborg; Hendrik J Vreman
Journal:  Pediatr Res       Date:  2021-11-17       Impact factor: 3.953

3.  Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue).

Authors:  Finn Ebbesen; Poul H Madsen; Pernille K Vandborg; Lasse H Jakobsen; Torleif Trydal; Hendrik J Vreman
Journal:  Pediatr Res       Date:  2016-05-25       Impact factor: 3.756

4.  Bilirubin photoconversion induced by monochromatic laser radiation. Comparison between aerobic and anaerobic experiments in vitro.

Authors:  M G Migliorini; P Galvan; G Sbrana; G P Donzelli; C Vecchi
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.